[27D-pm] Synthesis of labelled compounds/Radiopharmaceuticals 1

Mon. Mar 27, 2023 4:00 PM - 5:00 PM [Room D] Institute for the Advancement of Higher Education: S2 (Bldg. S: 2F)

Chair: Mitsutoshi Tsukimoto, Shozo Furumoto

+Add all to schedule

4:00 PM - 4:12 PM

[27D-pm01S] Development of the probe for radiotheranostics with albumin binder aiming to increase the therapeutic effects for At-211

○Hiroaki Echigo¹, Kenji Mishiro², Takeshi Fuchigami¹, Masayuki Munekane¹, Kohshin Washiyama³, Kazuhiro Takahashi³, Seigo Kinuya⁴, Kazuma Ogawa^1,2 (1. Grad. Sch. Pharm., Kanazawa Univ., 2. InFiniti., Kanazawa Univ., 3. Fukushima Med. Univ., 4. Grad. Sch. Med., Kanazawa Univ.)

4:12 PM - 4:24 PM

[27D-pm02S] Synthesis and evaluation of ²¹¹At-labeled sigma receptor ligands having 2-piperazino-1-cyclopentanol structure

○Kota Nishizawa¹, Kohshin Washiyama², Kenji Mishiro³, Masayuki Munekane¹, Takeshi Fuchigami¹, Kazuhiro Takahashi², Seigo Kinuya⁴, Kazuma Ogawa^1,3 (1. Grad. Sch. Pharm., Kanazawa Univ., 2. Fukushima Med. Univ., 3. InFiniti., Kanazawa Univ., 4. Grad. Sch. Med., Kanazawa Univ.)

4:24 PM - 4:36 PM

[27D-pm03S] Synthesis and evaluation of novel multifunctional chelating agents to control the biodistribution of radioimmunoconjugates.

○Kazuma Nakashima¹, Hiroyuki Watanabe¹, Masahiro Ono¹ (1. Grad. Sch. Pharm. Sci., Kyoto Univ.)

4:36 PM - 4:48 PM

[27D-pm04S] ¹¹¹In-labeled antibody to reduce nonspecific accumulation of radioactivity in the liver

○Masato Matsukawa¹, Hiroyuki Suzuki¹, Rikako Madokoro¹, Kento Kannaka¹, Tomoya Uehara¹ (1. Grad. Sch. Pharm. Sci., Chiba Univ.)

4:48 PM - 5:00 PM

[27D-pm05] Development of ⁶⁷Ga-labeled antibody fragments reducing non-specific renal radioactivity levels at early postinjection time

○Kento Kannaka¹, Saki Yamashita¹, Madoka Kobayashi¹, Reo Watanabe¹, Shunsuke Katamoto¹, Hiroyuki Suzuki¹, Tomoya Uehara¹ (1. Grad. Sch. Pharm. Sci., Chiba Univ.)

Session information

[27D-pm] Synthesis of labelled compounds/Radiopharmaceuticals 1

[27D-pm01S] Development of the probe for radiotheranostics with albumin binder aiming to increase the therapeutic effects for At-211

[27D-pm02S] Synthesis and evaluation of ²¹¹At-labeled sigma receptor ligands having 2-piperazino-1-cyclopentanol structure

[27D-pm03S] Synthesis and evaluation of novel multifunctional chelating agents to control the biodistribution of radioimmunoconjugates.

[27D-pm04S] ¹¹¹In-labeled antibody to reduce nonspecific accumulation of radioactivity in the liver

[27D-pm05] Development of ⁶⁷Ga-labeled antibody fragments reducing non-specific renal radioactivity levels at early postinjection time

Authentication

Session information

[27D-pm] Synthesis of labelled compounds/Radiopharmaceuticals 1

[27D-pm01S] Development of the probe for radiotheranostics with albumin binder aiming to increase the therapeutic effects for At-211

[27D-pm02S] Synthesis and evaluation of 211At-labeled sigma receptor ligands having 2-piperazino-1-cyclopentanol structure

[27D-pm03S] Synthesis and evaluation of novel multifunctional chelating agents to control the biodistribution of radioimmunoconjugates.

[27D-pm04S] 111In-labeled antibody to reduce nonspecific accumulation of radioactivity in the liver

[27D-pm05] Development of 67Ga-labeled antibody fragments reducing non-specific renal radioactivity levels at early postinjection time

Authentication

[27D-pm02S] Synthesis and evaluation of ²¹¹At-labeled sigma receptor ligands having 2-piperazino-1-cyclopentanol structure

[27D-pm04S] ¹¹¹In-labeled antibody to reduce nonspecific accumulation of radioactivity in the liver

[27D-pm05] Development of ⁶⁷Ga-labeled antibody fragments reducing non-specific renal radioactivity levels at early postinjection time